1 |
J. M. Brandner, Importance of tight junctions in relation to skin barrier function, Curr. Probl. Dermatol., 49, 27 (2016).
DOI
|
2 |
J. Chen and M. Zhang, The Par3/Par6/aPKC complex and epithelial cell polarity, Exp. Cell Res., 319(10), 1357 (2013).
DOI
|
3 |
D. Gunzel and A. S. Yu, Claudins and the modulation of tight junction permeability, Physiol. Rev., 93(2), 525 (2013).
DOI
|
4 |
M. S. Balda, and K. Matter, Tight junctions and the regulation of gene expression, Biochim. Biophys. Acta -Biomembr., 1788(4), 761 (2009).
DOI
|
5 |
J. M. Brandner, Tight junctions and tight junction proteins in mammalian epidermis, Eur. J. Pharm. Biopharm., 72(2), 289 (2009).
DOI
|
6 |
J. A. Guttman, and B. B. Finlay, Tight junctions as targets of infectious agent, Biochim. Biophys. Acta., 1788(4), 832 (2009).
DOI
|
7 |
H. A. Ed ens, B. P. Levi, D. L. Jaye, S. Walsh, T. A. Reaves, J. R. Turner, A. Nusrat, and C. A. Parkos, Neutrophil transepithelial migration: evidence for sequential, contact-dependent signaling events and enhanced paracellular permeability independent of transjunctional migration, J. Immun., 169(1), 476 (2002).
DOI
|
8 |
A. Fukui, Y. Naito, O. Handa, M. Kugai, T. Tsuji, H. Yoriki, Y. Qin, S. Adachi, Y. Higashimura, K. Mizushima, K. Kamad a, K. Katad a, K. Uchiyama, T. Ishikawa, T. Takagi, N. Yagi, S. Kokura, and T. Yoshikawa, Acetyl salicylic acid induces damage to intestinal epithelial cells by oxidation-related modifications of ZO-1, Am. J. Physiol. - Gastrointest. Liver Physiol., 303(8), G927 (2012).
DOI
|
9 |
J. M. Brandner, S. Kief, C. Grund, M. Rendl, P. Houdek, C. Kuhn, E. Tschachler, W. W. Franke, and I. Moll, Organization and formation of the tight junction system in human epidermis and cultured keratinocytes, Eur. J. Cell Biol., 81(5), 253 (2002).
DOI
|
10 |
E. S. Barton, J. C. Forrest, J. L. Connolly, J. D. Chappell, Y. Liu, F. J. Schnell, A. Nusrat, C. A. Parkos, and T. S. Dermody, Junction adhesion molecule is a receptor for reovirus, Cell, 104(3), 441 (2001).
DOI
|
11 |
Y. Hashimoto, K. Tachibana, S. M. Krug, J. Kunisawa, M. Fromm, and M. Kondoh, Potential for tight junction protein-directed drug development using claudin binders and angubindin-1, Int. J. Mol. Sci., 20(16), 4016 (2019).
DOI
|
12 |
E. Proksch, J. M. Brandner, and J. M. Jensen, The skin: an indispensable barrier, Exp. Dermatol., 17(12), 1063 (2008).
DOI
|
13 |
C. M. Van Itallie and J. M. Anderson, The molecular physiology of tight junction pores, Physiology (Bethesda), 19, 331 (2004).
DOI
|
14 |
J. M. Brandner, S. Kief, E. Wladykowski, P. Houdek, and I. Moll, Tight junction proteins in the skin, Skin Pharmacol. Physiol., 19(2):71 (2006).
DOI
|
15 |
A. Arabzadeh, T. C. Troy, and K. Turksen, Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis, BMC cancer, 7, 196 (2007).
DOI
|
16 |
M. Reithofer and B. Jahn-Schmid, Allergens with protease activity from house dust mites, Int. J. Mol. Sci., 18(7), 1368 (2017).
DOI
|
17 |
J. Shi, M. Barakat, D. Chen, and L. Chen, Bicellular tight junctions and wound healing, Int. J. Mol. Sci., 19(12), 3862 (2018).
DOI
|
18 |
T. Yuki, A. Haratake, H. Koishikawa, K. Morita, Y. Miyachi, and S. Inoue, Tight junction proteins in keratinocytes: localization and contribution to barrier function, Exp. Dermatol., 16(4), 324 (2007).
DOI
|
19 |
A. Veshnyakova, J. Protze, J. Rossa, I. E. Blasig, G. Krause, and J. Piontek, On the interaction of Clostridium perfringens enterotoxin with claudins, Toxins (Basel)., 2(6), 1336 (2010).
DOI
|
20 |
S. Maher, T. W. Leonard, J. Jacobsen, and D. J. Brayden, Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic, Adv. Drug Deliv. Rev., 61(15), 1427 (2009).
DOI
|
21 |
J. A. Palatinus, M. P. O'Quinn, R. J. Barker, B. S. Harris, J. Jourdan, and R. G. Gourdie, ZO-1 determines adherens and gap junction localization at intercalated disks, Am. J. Physiol. - Heart Circ. Physiol., 300(2), H583 (2011).
DOI
|
22 |
J. S. Kim and H. S. Jang, The expression pattern of the tight junction protein occludin in the epidermal context when comparing various physical samples, Korean Journal of Clinical Laboratory Science, 47(4), 267 (2015).
DOI
|
23 |
J. M. Anderson, and C. M. Van Itallie, Physiology and function of the tight junction, Cold Spring Harb. Perspect. Biol., 1(2), a002584 (2009).
DOI
|
24 |
M. Lal-Nag and P. J. Morin, The claudins, Genome Biol., 10(8), 1 (2009).
|
25 |
I. Benedicto, F. Molina-Jimenez, B. Bartosch, F. L. Cosset, D. Lavillette, J. Prieto, R. Moreno-Otero, A. ValenzuelaFernandez, R. Aldabe, M. Lopez-Cabrera, and P. L. Majano, The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection, J. Virol., 83(16), 8012 (2009).
DOI
|
26 |
M. Furuse, M. Hata, K. Furuse, Y. Yoshida, A. Haratake, Y. Sugitani, T. Noda, A. Kubo, and S. Tsukita, Claudinbased tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice, J. Cell Biol., 156(6), 1099 (2002).
DOI
|
27 |
I. Helfrich, A. Schmitz, P. Zigrino, C. Michels, I. Haase, A. le Bivic, M. Leitges, and C. M. Niessen, Role of aPKC isoforms and their binding partners Par3 and Par6 in epidermal barrier formation, J. Invest. Dermatol., 127(4), 782 (2007).
DOI
|
28 |
A. E. Mertens, T. P. Rygiel, C. Olivo, R. van der Kammen, and J. G. Collard, The Rac activator Tiam1 controls tight junction biogenesis in keratinocytes through binding to and activation of the Par polarity complex, J. Cell Biol., 170(7), 1029 (2005).
DOI
|
29 |
M. Kondoh, T. Yoshida, H. Kakutani, and K. Yagi, Targeting tight junction proteins-significance for drug development, Drug Discov., 13(3-4), 180 (2008).
|
30 |
J. Brunner, S. Ragupathy, and G. Borchard, Target specific tight junction modulators, Adv. Drug Deliv. Rev., 171, 266 (2021).
DOI
|
31 |
M. A. Deli, Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery, Biochim. Biophys. Acta, 1788(4), 892 (2009).
DOI
|
32 |
E. K. Anderberg, T. Lindmark, and P. Artursson, Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route, Pharm. Res., 10(6), 857 (1993).
DOI
|
33 |
N. N. Salama, N. D. Eddington, and A. Fasano, Tight junction modulation and its relationship to drug delivery, Adv. Drug Deliv. Rev., 58(1), 15 (2006).
DOI
|
34 |
T. Otani and M. Furuse, Tight junction structure and function revisited, Trends Cell Biol., 30(10), 805 (2020).
DOI
|
35 |
C. M. Niessen, Tight junctions/adherens junctions: basic structure and function, J. Invest. Dermatol., 127(11), 2525 (2007).
DOI
|
36 |
R. Gruber, C. Bornchen, K. Rose, A. Daubmann, T. Volksd orf, E. Wlad ykowski, S. Vid al-Y-Sy, E. M. Peters, M. Danso, J. A. Bouwstra, H. C. Hennies, I. Moll, M. Schmuth, and J. M. Brandner, Diverse regulation of claudin-1 and claudin-4 in atopic dermatitis, Am. J. Clin. Pathol., 185(10), 2777 (2015).
DOI
|
37 |
M. Furuse, M. Hata, K. Furuse, Y. Yoshida, A. Haratake, Y. Sugitani, T. Noda, A. Kubo, and S. Tsukita, Claudinbased tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice, J. Cell Biol., 156(6), 1099 (2002).
DOI
|
38 |
C. Leyvraz, R. P. Charles, I. Rubera, M. Guitard, S. Rotman, B. Breiden, K. Sandhoff, and E. Hummler, The epidermal barrier function is dependent on the serine protease CAP1/Prss8, J. Cell Biol., 170(3), 487 (2005).
DOI
|
39 |
J. M. Brandner, Pores in the epidermis: aquaporins and tight junctions, Int. J. Cosmet. Sci., 29(6), 413 (2007).
DOI
|
40 |
U. Ohnemus, K. Kohrmeyer, P. Houdek, H. Rohde, E. Wladykowski, S. Vidal, M. A. Horstkotte, M. Aepfelbacher, N. Kirschner, M. J. Behne, I. Moll, and J. M. Brandner, Regulation of epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains, J. Invest. Dermatol., 128(4), 906 (2008).
DOI
|
41 |
C. Gorzelanny, C. Mess, S. W. Schneid er, V. Huck, and J. M. Brandner, Skin barriers in dermal drug delivery: which barriers have to be overcome and how can we measure them?, Pharmaceutics, 12(7), 684 (2020).
DOI
|
42 |
M. Kopecna, M. Machacek, A. Novackova, G. Paraskevopoulos, J. Roh, and K. Vavrova, Esters of terpene alcohols as highly potent, reversible, and low toxic skin penetration enhancers, Sci. Rep., 9(1), 14617 (2019).
DOI
|
43 |
T. C. Troy, A. Arabzadeh, N. M. Lariviere, A. Enikanolaiye, and K. Turksen, Dermatitis and agingrelated barrier dysfunction in transgenic mice overexpressing an epidermal-targeted claudin 6 tail deletion mutant, PLoS One, 4(11), e7814 (2009).
DOI
|
44 |
J. M. Brandner, M. Zorn-Kruppa, T. Yoshida, I. Moll, L. A. Beck, and A. De Benedetto, Epidermal tight junctions in health and disease. Tissue barriers, 3(1-2), e974451 (2015).
DOI
|
45 |
K. Nagasawa, H. Chiba, H. Fujita, T. Kojima, T. Saito, T. Endo, and N. Sawada, Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells, J. Cell. Physiol, 208(1), 123 (2006).
DOI
|
46 |
H. Lan, K. Hosomi, and J. Kunisawa, Clostridium perfringens enterotoxin-based protein engineering for the vaccine design and delivery system, Vaccine, 37(42), 6232 (2019).
DOI
|
47 |
K. Basler, S. Bergmann, M. Heisig, A. Naegel, M. Zorn-Kruppa, and J. M. Brandner, The role of tight junctions in skin barrier function and dermal absorption, J. Control Release, 242, 105 (2016).
DOI
|